|
1
|
Gach O, El HZ and Lancellotti P: Acute
coronary syndrome. Rev Med Liege. 73:243–250. 2018.(In French).
PubMed/NCBI
|
|
2
|
Wang R, Wang M, Ye J, Sun G and Sun X:
Mechanism overview and target mining of atherosclerosis:
Endothelial cell injury in atherosclerosis is regulated by
glycolysis (Review). Int J Mol Med. 47:65–76. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kristensen SD, Ravn HB and Falk E:
Insights into the pathophysiology of unstable coronary artery
disease. Am J Cardiol. 80:5E–9E. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Freedman JE and Loscalzo J: Nitric oxide
and its relationship to thrombotic disorders. J Thromb Haemost.
1:1183–1188. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McGuire DK, Emanuelsson H, Granger CB, E
Magnus Ohman, D J Moliterno, H D White, D Ardissino, J W Box, R M
Califf and E J Topol: Influence of diabetes mellitus on clinical
outcomes across the spectrum of acute coronary syndromes. Findings
from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J.
21:1750–1758. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hildebrandt P: Diabetic patients and acute
coronary syndromes. Eur Heart J. 22:887–888. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han D, Rozanski A, Gransar H, Sharir T,
Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ,
et al: Myocardial ischemic burden and differences in prognosis
among patients with and without diabetes: Results from the
multicenter international REFINE SPECT registry. Diabetes Care.
43:453–459. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wackers FJ, Young LH, Inzucchi SE, Chyun
DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV,
Filipchuk N, et al: Detection of silent myocardial ischemia in
asymptomatic diabetic subjects: The DIAD study. Diabetes Care.
27:1954–1961. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinez MC, Tesse A, Zobairi F and
Andriantsitohaina R: Shed membrane microparticles from circulating
and vascular cells in regulating vascular function. Am J Physiol
Heart Circ Physiol. 288:H1004–H1009. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zaldivia MTK, McFadyen JD, Lim B, Wang X
and Peter K: Platelet-derived microvesicles in cardiovascular
diseases. Front Cardiovasc Med. 4:742017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han WQ, Chang FJ, Wang QR and Pan JQ:
Microparticles from patients with acute coronary syndrome impair
vasodilatation by inhibiting the Akt/eNOS-Hsp90 signaling pathway.
Cardiology. 132:252–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koga H, Sugiyama S, Kugiyama K, Watanabe
K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H and
Ogawa H: Elevated levels of VE-cadherin-positive endothelial
microparticles in patients with type 2 diabetes mellitus and
coronary artery disease. J Am Coll Cardiol. 45:1622–1630. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boulanger CM, Scoazec A, Ebrahimian T,
Henry P, Mathieu E, Tedgui A and Mallat Z: Circulating
microparticles from patients with myocardial infarction cause
endothelial dysfunction. Circulation. 104:2649–2652. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng G, Shan XF, Wang XL, Dong WW, Li Z,
Liu XH, Zhang W, Xing K and Chang FJ: Endothelial damage effects of
circulating microparticles from patients with stable angina are
reduced by aspirin through ERK/p38 MAPKs pathways. Cardiovasc Ther.
35:2017. View Article : Google Scholar
|
|
16
|
Ci HB, Ou ZJ, Chang FJ, Liu DH, He GW, Xu
Z, Yuan HY, Wang ZP, Zhang X and Ou JS: Endothelial microparticles
increase in mitral valve disease and impair mitral valve
endothelial function. Am J Physiol Endocrinol Metab. 304:E695–E702.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wen B, Combes V, Bonhoure A, Weksler BB,
Couraud PO and Grau GE: Endotoxin-induced monocytic microparticles
have contrasting effects on endothelial inflammatory responses.
PLoS One. 9:e915972014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colle IO, De Vriese AS, Van Vlierberghe
HR, Lameire NH and De Vos MM: Vascular hyporesponsiveness in the
mesenteric artery of anaesthetized rats with cirrhosis and portal
hypertension: An in-vivo study. Eur J Gastroenterol Hepatol.
16:139–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Erol A and Koşay S: Effects of
aminoguanidine administration on vascular hyporeactivity in
thoracic aorta from endotoxaemic rats. Eur J Pharmacol.
408:175–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin S, Tesse A, Hugel B, Martínez MC,
Morel O, Freyssinet JM and Andriantsitohaina R: Shed membrane
particles from T lymphocytes impair endothelial function and
regulate endothelial protein expression. Circulation.
109:1653–1659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Biasucci LM, Porto I, Di Vito L, De Maria
GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F,
Capogrossi MC and Crea F: Differences in microparticle release in
patients with acute coronary syndrome and stable angina. Circ J.
76:2174–2182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bernal-Mizrachi L, Jy W, Fierro C,
Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL,
Ferreira A, de Marchena E and Ahn YS: Endothelial microparticles
correlate with high-risk angiographic lesions in acute coronary
syndromes. Int J Cardiol. 97:439–446. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu FB and Stampfer MJ: Is type 2 diabetes
mellitus a vascular condition? Arterioscler Thromb Vasc Biol.
23:1715–1716. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ceriello A and Motz E: Is oxidative stress
the pathogenic mechanism underlying insulin resistance, diabetes,
and cardiovascular disease? The common soil hypothesis revisited.
Arterioscler Thromb Vasc Biol. 24:816–823. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang X, Luo YX, Chen HZ and Liu DP:
Mitochondria, endothelial cell function, and vascular diseases.
Front Physiol. 5:1752014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wong WT, Wong SL, Tian XY and Huang Y:
Endothelial dysfunction: The common consequence in diabetes and
hypertension. J Cardiovasc Pharmacol. 55:300–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang F, Guo X, Shen X, Kream RM, Mantione
KJ and Stefano GB: Vascular dysfunction associated with type 2
diabetes and Alzheimer's disease: A potential etiological linkage.
Med Sci Monit Basic Res. 20:118–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Münzel T: Endothelial dysfunction:
Pathophysiology, diagnosis and prognosis. Dtsch Med Wochenschr.
133:2465–2470. 2008.(In German). View Article : Google Scholar
|
|
29
|
Tejero J, Shiva S and Gladwin MT: Sources
of vascular nitric oxide and reactive oxygen species and their
regulation. Physiol Rev. 99:311–379. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Voldstedlund M, Vinten J and Tranum-Jensen
J: Cav-p60 expression in rat muscle tissues. Distribution of
caveolar proteins. Cell Tissue Res. 306:265–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mineo C and Shaul PW: Regulation of eNOS
in caveolae. Adv Exp Med Biol. 729:51–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meye C, Schumann J, Wagner A and Gross P:
Effects of homocysteine on the levels of caveolin-1 and eNOS in
caveolae of human coronary artery endothelial cells.
Atherosclerosis. 190:256–263. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qin L, Zhu N, Ao BX, Liu C, Shi YN, Du K,
Chen JX, Zheng XL and Liao DF: Caveolae and caveolin-1 integrate
reverse cholesterol transport and inflammation in atherosclerosis.
Int J Mol Sci. 17:4292016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao YY, Liu Y, Stan RV, Fan L, Gu Y,
Dalton N, Chu PH, Peterson K, Ross J Jr and Chien KR: Defects in
caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension
in knockout mice. Proc Natl Acad Sci USA. 99:11375–11380. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pechánová O and Simko F: The role of
nitric oxide in the maintenance of vasoactive balance. Physiol Res.
2 (Suppl 56):S7–S16. 2007.
|
|
36
|
Yetik-Anacak G and Catravas JD: Nitric
oxide and the endothelium: History and impact on cardiovascular
disease. Vascul Pharmacol. 45:268–276. 2006. View Article : Google Scholar : PubMed/NCBI
|
